東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back to Search results for [ null ]

Switch To: Labeled | MARC Mode | ISBD

SOX7 is downregulated and functions ...

Stovall, Daniel B.

Linked to FindBook

Google Book

Amazon

博客來

SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer.

Record Type:	Electronic resources : Monograph/item
Title/Author:	SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer./
Author:	Stovall, Daniel B.
Description:	134 p.
Notes:	Source: Dissertation Abstracts International, Volume: 75-11(E), Section: B.
Contained By:	Dissertation Abstracts International75-11B(E).
Subject:	Molecular biology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3629980
ISBN:	9781321075465

SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer.
Stovall, Daniel B.

SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer. - 134 p.

Source: Dissertation Abstracts International, Volume: 75-11(E), Section: B.

Thesis (Ph.D.)--Wake Forest University, 2014.

This item must not be sold to any third party vendors.

Second only to lung cancer, breast cancer is the leading cause of cancer-related deaths in American women. Breast cancer is a heterogeneous set of diseases characterized by aberrant genetic and epigenetic states, often leading to the ablation of tumor suppressors. Loss of tumor suppressor function has been established as a driver of disease progression in breast cancer patients. Thus, understanding the deregulation of tumor suppressor activity may lead to the identification of potential therapeutic targets whose inhibition can restore tumor suppressor function and, consequently, an anti-proliferative cellular state.

ISBN: 9781321075465Subjects--Topical Terms:

517296
Molecular biology.

SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer.
LDR:03850nmm a2200325 4500 001 2059478
005 20150805065220.5
008 170521s2014 ||||||||||||||||| ||eng d
020 $a 9781321075465
035 $a (MiAaPQ)AAI3629980
035 $a AAI3629980
040 $a MiAaPQ $c MiAaPQ
100 1 $a Stovall, Daniel B. $3 3173553
245 1 0 $a SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer.
300 $a 134 p.
500 $a Source: Dissertation Abstracts International, Volume: 75-11(E), Section: B.
500 $a Adviser: Guangchao Sui.
502 $a Thesis (Ph.D.)--Wake Forest University, 2014.
506 $a This item must not be sold to any third party vendors.
520 $a Second only to lung cancer, breast cancer is the leading cause of cancer-related deaths in American women. Breast cancer is a heterogeneous set of diseases characterized by aberrant genetic and epigenetic states, often leading to the ablation of tumor suppressors. Loss of tumor suppressor function has been established as a driver of disease progression in breast cancer patients. Thus, understanding the deregulation of tumor suppressor activity may lead to the identification of potential therapeutic targets whose inhibition can restore tumor suppressor function and, consequently, an anti-proliferative cellular state.
520 $a The Sex-determining region Y-box (SOX) family of transcription factors plays important roles in development, and several of its members have also been heavily implicated in a variety of cancers. In particular, SOX7 downregulation and tumor suppressive activities have been reported in a variety of epithelial tumors, including those of the lung, colon, and prostate. However, the precise functions of SOX7 as a DNA-binding transcription factor remained understudied. We set out to interrogate the role of SOX7 in breast cancer and the mechanism behind its tumor-specific depletion. We report the frequent and striking downregulation of SOX7 in several breast cancer cell lines and breast tumor tissues, compared to normal mammary epithelia. The SOX7 promoter is frequently methylated in breast cancer cell lines, and SOX7 mRNA, but not protein, levels increase in response to pharmacologic or shRNA-mediated silencing of DNA methyltransferases (DNMTs). However, DNA methylation in breast tumor tissues is less common. Thus, we investigated the contribution of miRNAs to SOX7 downregulation and observed inhibition of a reporter plasmid with the SOX7 3' untranslated region (UTR) in response to cotransfection with miR-182. Further, we correlated reduced SOX7 expression in breast cancer cell lines and tumor tissues with levels of a noncoding RNA transcript, reverse-SOX7. Importantly, SOX7 expression correlates with better distant metastasis-free survival in breast cancer patients, indicating its clinical relevance as a potential prognostic marker for breast cancer. To assess the functional role of SOX7 in breast cancer, we generated constructs to silence SOX7 expression using shRNA and introduced Doxycycline-inducible ectopic SOX7. With these tools, we demonstrated the tumor suppressive role of SOX7 in breast cancer cells both in vitro and in vivo. We explored the transcriptional activities of SOX7 using a microarray, and identified several cancer-related pathways that are regulated by SOX7.
520 $a Collectively, our work demonstrates a critical role for SOX7 in antagonizing neoplastic transformation of mammary cells and explores multiple mechanisms by which breast tumors downregulate SOX7 expression.
590 $a School code: 0248.
650 4 $a Molecular biology. $3 517296
650 4 $a Cellular biology. $3 3172791
650 4 $a Oncology. $3 751006
690 $a 0307
690 $a 0379
690 $a 0992
710 2 $a Wake Forest University. $b Cancer Biology. $3 3173554
773 0 $t Dissertation Abstracts International $g 75-11B(E).
790 $a 0248
791 $a Ph.D.
792 $a 2014
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3629980